The most common reason is that the company has never committed to a specific buyer. They have interest from multiple directions — different verticals, different buyer types, different use cases — and they're pursuing all of them simultaneously. Traction is real, but it's not compounding because there's no single focus strong enough to make sales, messaging, product, and fundraising reinforce each other. The transition from early traction to compounding growth requires a narrowing decision that most teams avoid.

The Category Buyer Trap is a pattern where companies describe their target customer as a market category — "enterprise companies," "CEOs," "SMEs" — rather than a specific person with a title, a budget, and a problem they're actively trying to solve this week. Categories are populations, not buyers. When a company can't name a specific buyer, everything downstream — the pitch, the pricing, the feature roadmap, the investor narrative — remains provisional.

Because European traction proves the product works — it doesn't prove that a specific US buyer has the same problem, at the same urgency, with the same willingness to pay. When a company presents European revenue as evidence of US product-market fit without validating the US buyer thesis independently, investors hear a technology story, not a go-to-market story. The objection isn't about the product. It's about the buyer thesis.

Yes. The format is designed for cohort delivery and has been delivered to programs including INNOVIT's Startup Bootcamp. If you run a program for post traction or funded companies preparing for US market entry, product launch or expanding beyond founder-led sales, reach out to discuss how the diagnostic fits your program structure.

Yes, and the mix is a feature rather than a compromise. The patterns surface differently by stage, so a room with both gets a cross-pollination effect: earlier founders watch an established company get pressure-tested and learn that traction immunizes no one, while established founders watch a startup commit to a single buyer and remember what focus looks like. Because the session works on each company's own decisions rather than delivering stage-specific content, every founder is doing real work on their own business at the same time, regardless of stage.

It works across stages, and it often cuts deepest for established companies. The reason is counterintuitive: the more a company has already built, the more it has to unlearn when entering a new market. Early startups are pressure-tested on focus, on whether they've committed to a single buyer instead of spreading across many. Established companies are pressure-tested on transfer, on whether the traction they earned in one market actually proves a buyer exists in the next one with the same urgency. Both leave with sharper decisions. The diagnostic adapts to where a company actually is, rather than teaching a fixed curriculum.

Most founder sessions deliver content: an expert shares frameworks or advice, and founders absorb it. The Founder Working Session doesn't add information, it forces decisions. Founders work on their own business under live questioning and leave having committed to something they'd been avoiding. It also adapts to each cohort rather than running a fixed curriculum, so the session presses on whatever that particular group is actually stuck on. It's designed to complement the rest of a program, not repeat it.

Yes. In person is recommended, because the pressure and the peer effect are strongest in a room together, but the session has been run virtually and adapts to a remote format.